Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003768 |
---|---|
Receipt number | R000004562 |
Scientific Title | A phase II trial of adjuvant chemotherapy with 5-FU liver perfusion chemotherapy via the portal vein followed by gemcitabine plus S-1 (F-GS therapy) for patients with resectable pancreatic cancer (CCOG-1001) |
Date of disclosure of the study information | 2010/06/17 |
Last modified on | 2013/01/17 14:36:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/06/17 00:43:15 | ||
2 | Update | 2010/06/17 00:45:47 | Public title Public title |
|
3 | Update | 2010/06/17 00:52:43 | Recruitment status |
|
4 | Update | 2010/12/17 13:28:14 | Address |
|
5 | Update | 2013/01/17 14:36:17 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2013/01/17 14:36:43 | Recruitment status |